77 Capital
77 Capital backs early-stage Indian startups at Pre-Seed and Seed stages, focusing on SaaS, B2B marketplaces, FinTech, and HealthTech through a syndicate model that brings together aligned capital and operator networks.
At a glance
Key signals founders use to decide if this investor is worth a conversation.
Where they invest
Stages and sectors this investor typically backs.
Investment thesis
Themes this investor is mapped to across the VC Dekho directory.
77 Capital backs early-stage Indian startups at Pre-Seed and Seed stages, focusing on SaaS, B2B marketplaces, FinTech, and HealthTech through a syndicate model that brings together aligned capital and operator networks.
Portfolio companies
6 companies mapped to this fund.
About 77 Capital
Background and context for founders evaluating this investor.
77 Capital is an Indian investment syndicate that writes cheques of USD 75,000 to 100,000 into Pre-Seed and Seed stage startups. Its portfolio reflects a clear conviction around B2B software and infrastructure businesses, with investments spanning enterprise and SMB SaaS, B2B marketplaces, fintech, and health tech. Companies like M2P and Hyperface signal comfort with fintech infrastructure and API-led business models, while Clinikally and Fego point to interest in digital health and consumer wellness built on strong tech foundations. Vidyut Tech and Mewt further demonstrate a pattern of backing asset-light, scalable Indian startups solving real enterprise or platform problems. As a syndicate, 77 Capital offers founders more than just capital; the model typically means co-investors and domain-relevant angels come in alongside the lead, which can be valuable for startups seeking both money and market access. Founders pitching to 77 Capital should be prepared to articulate clear unit economics, a defensible B2B go-to-market strategy, and a path to scalable revenue. The typical entry point is early enough to help shape the company, making a crisp product narrative and a strong founding team the most important factors in the conversation.
Its portfolio reflects a clear conviction around B2B software and infrastructure businesses, with investments spanning enterprise and SMB SaaS, B2B marketplaces, fintech, and health tech.
Notes
Mewt, Fego, Clinikally, Vidyut Tech, M2P, Hyperface
Investment criteria
Tend to turnaround quickly, primarily calls with the founders + 3rd party due diligence (if required)
Data confidence: Unverified – inferred
Investors at 77 Capital
Partners and principals mapped to this fund in the directory.
Similar funds
Other funds that overlap on stage, sector, or thesis.
Open BlueLotus Ventures
Syndicate / NetworkBlueLotus VenturesStagesPre-SeedSectorsSaaS / Enterprise, Fintech, Consumer / D2C · Early-stage builders, Founder-led / operator capitalTicket$100K – $150KOpen Cloud Capital
Syndicate / NetworkCloud CapitalStagesPre-Seed, Pre-Series ASectorsSaaS / Enterprise, Fintech, Consumer / D2C · Early-stage builders, Founder-led / operator capitalTicket$100K – $150KOpen Growth valley
Syndicate / NetworkGrowth valleyStagesPre-Seed, Pre-Series A, Series BSectorsSaaS / Enterprise, Fintech, Consumer / D2C · Early-stage builders, Founder-led / operator capitalTicketNot listedOpen ah! Ventures
Syndicate / Networkah! VenturesStagesPre-Seed, Pre-Series ASectorsSaaS / Enterprise, Fintech, Consumer / D2C · Early-stage builders, Founder-led / operator capitalTicket$361K – $602KOpen Ashvik Kapital Syndicate / NetworkAshvik KapitalStagesPre-Seed, Pre-Series ASectorsFintech, Consumer / D2C, Healthcare / Medtech · Early-stage builders, Founder-led / operator capitalTicket$100K – $1MOpen Long Tail Ventures Venture CapitalLong Tail VenturesStagesPre-Seed, Pre-Series ASectorsSaaS / Enterprise, Fintech, Consumer / D2C · Early-stage builders, Founder-led / operator capitalTicket$35K – $100K
Explore related
Jump into stage, sector, and thesis mapped to this fund.